Find A Portfolio/Ticker
Comparison Box
MyPlanIQ
DUPAGE MEDICAL GROUP LTD PROFIT SHARING 401K PLAN
DUPAGE MEDICAL GROUP LTD PROFIT SHARING 401K PLAN Strategic Asset Allocation - Equal Weight Moderate
DUPAGE MEDICAL GROUP LTD PROFIT SHARING 401K PLAN Strategic Asset Allocation - Equal Weight Moderate
live (public) 0.21% February 28
Delayed
Holdings (As of 10/31/2024)
sign up and login first and then customize a new portfolio for the latest current holdings
Asset | Fund in this portfolio | Price change* | Original Fund Description | Percentage |
---|---|---|---|---|
CASH | CASH (CASH) | 0.0% | Vanguard Retirement Savings TR IV | 0.00% |
International Equity | VXUS (Vanguard Total International Stock ETF) | 0.58% | Vanguard Total International Stock IS | 14.42% |
General Bond | NEZYX (LOOMIS SAYLES STRATEGIC INCOME FUND CLASS Y) | 0.16% | Loomis Strategic Inc Y | 18.93% |
General Bond | PTTRX (TOTAL RETURN FUND INSTITUTIONAL) | 0.23% | PIMCO Total Return INST | 16.42% |
US Equity | TBCIX (T. ROWE PRICE BLUE CHIP GROWTH FUND INC. T. ROWE PRICE BLUE CHIP GROWTH FUND-I CLASS) | 2.49% | TRow Price Blue Chip Growth I | 7.45% |
US Equity | FXAIX (Fidelity 500 Index Fund) | 1.85% | Fidelity 500 Index | 6.04% |
Real Estate | DFGEX (DFA Global Real Estate Securities Ptf) | 1.60% | DFA Global Real Estate | 9.42% |
Commodities | DCMSX (DFA Commodity Strategy I) | 0.66% | DFA Commodity Strategy | 13.69% |
Emerging Market Equity | ODVIX (Oppenheimer Developing Markets Cl I) | 0.84% | Oppenheimer Developing Markets I | 13.63% |
* Day change on 10/31/2024.

Beta
Performance (As of 02/28/2025)
Since 12/31/2000
Name | YTD* Return |
1Yr AR** |
3Yr AR** |
5Yr AR** |
10Yr AR** |
15Yr AR** |
---|---|---|---|---|---|---|
DUPAGE MEDICAL GROUP LTD PROFIT SHARING 401K PLAN Strategic Asset Allocation - Equal Weight Moderate | 4.6% | 12.1% | 8.2% | 9.4% | 6.5% | 6.3% |
VFINX (Vanguard (S&P 500) Index) | 1.8% | 13.8% | 15.7% | 17.5% | 12.8% | 13.8% |
VBINX (Vanguard Balance (60% stocks/40% bonds) | 0.0% | 4.6% | 6.8% | 7.2% | 6.7% | 8.2% |
* YTD: Year to Date
** AR: Annualized Return
** portfolio AR is delayed
Last 1 Week* | YTD*(2025) | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 15 Yr | 20 Yr | 20 Yr | Since 01/02/2001 |
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annualized Return(%) | 0.5 | 4.6 | 12.1 | 8.2 | 9.4 | 6.5 | 6.3 | 6.6 | 5.9 | 6.1 | 6.2 | 3.5 | 7.2 | -4.0 | 20.9 | 14.0 | 17.3 | -6.8 | 13.0 | 6.0 | -5.0 | 0.8 | 4.9 | 11.7 | -3.6 | 17.0 | 29.1 | -25.7 | 7.9 | 12.9 | 8.2 | 12.1 | 23.0 | -5.2 | 3.4 |
Sharpe Ratio | NA | 0.36 | -0.1 | -0.13 | 0.51 | 0.44 | NA | NA | NA | NA | 0.43 | -0.39 | 0.4 | -0.51 | 1.02 | 0.88 | 2.92 | -1.01 | 3.16 | 0.75 | -0.7 | 0.15 | 0.72 | 1.66 | -0.27 | 1.27 | 1.39 | -1.08 | 0.45 | 1.2 | 0.94 | 1.47 | 2.88 | -0.56 | 0.11 |
Draw Down(%) | NA | 1.8 | 6.6 | 12.9 | 17.7 | 19.6 | NA | NA | NA | NA | 41.3 | 6.6 | 7.6 | 12.9 | 6.9 | 19.6 | 2.7 | 11.9 | 2.2 | 6.0 | 9.8 | 5.5 | 8.2 | 6.1 | 15.1 | 10.0 | 20.8 | 38.3 | 7.2 | 8.8 | 4.5 | 8.1 | 8.6 | 18.9 | 11.3 |
Standard Deviation(%) | NA | 6.4 | 7.7 | 8.7 | 13.3 | 10.5 | NA | NA | NA | NA | 11.6 | 7.7 | 7.4 | 10.6 | 20.5 | 15.6 | 5.4 | 8.1 | 3.9 | 7.8 | 7.2 | 5.5 | 6.7 | 7.0 | 13.4 | 13.3 | 20.9 | 24.8 | 10.9 | 8.0 | 6.4 | 7.6 | 7.7 | 11.3 | 9.9 |
Treynor Ratio | NA | 0.06 | -0.02 | -0.03 | 0.16 | 0.11 | NA | NA | NA | NA | 0.1 | -0.06 | 0.06 | -0.15 | 0.29 | 0.33 | 0.44 | -0.19 | 0.36 | 0.11 | -0.13 | 0.02 | 0.1 | 0.24 | -0.07 | 0.24 | 0.4 | -0.47 | 0.08 | 0.14 | 0.11 | 0.22 | 0.61 | -0.17 | 0.03 |
Alpha | NA | 0.05 | -0.02 | -0.02 | 0.01 | 0.0 | NA | NA | NA | NA | 0.01 | -0.04 | -0.02 | 0.01 | 0.01 | 0.02 | 0.02 | -0.02 | 0.02 | 0.0 | -0.02 | -0.01 | -0.03 | 0.02 | -0.02 | 0.03 | 0.04 | -0.02 | 0.02 | 0.01 | 0.02 | 0.03 | 0.05 | 0.01 | 0.02 |
Beta | NA | 0.38 | 0.47 | 0.41 | 0.43 | 0.43 | NA | NA | NA | NA | 0.5 | 0.48 | 0.46 | 0.36 | 0.71 | 0.41 | 0.36 | 0.43 | 0.34 | 0.51 | 0.38 | 0.41 | 0.51 | 0.48 | 0.54 | 0.7 | 0.73 | 0.57 | 0.64 | 0.71 | 0.54 | 0.52 | 0.36 | 0.37 | 0.38 |
RSquared | NA | 0.63 | 0.62 | 0.64 | 0.44 | 0.49 | NA | NA | NA | NA | 0.68 | 0.61 | 0.67 | 0.66 | 0.18 | 0.84 | 0.67 | 0.82 | 0.34 | 0.74 | 0.69 | 0.71 | 0.71 | 0.76 | 0.88 | 0.9 | 0.91 | 0.9 | 0.9 | 0.77 | 0.74 | 0.57 | 0.64 | 0.71 | 0.68 |
Sortino Ratio | NA | 0.54 | -0.13 | -0.18 | 0.82 | 0.69 | NA | NA | NA | NA | 0.61 | -0.51 | 0.59 | -0.72 | 2.43 | 1.11 | 4.62 | -1.29 | 5.09 | 1.05 | -0.93 | 0.21 | 0.97 | 2.56 | -0.35 | 1.84 | 2.02 | -1.4 | 0.61 | 1.79 | 1.41 | 2.03 | 4.4 | -0.79 | 0.15 |
Yield(%) | N/A | 0.1 | 1.8 | 2.9 | 5.8 | 4.8 | 5.6 | 5.6 | 7.1 | 7.1 | 4.25 | 2.1 | 3.4 | 3.2 | 12.1 | 2.2 | 3.4 | 2.7 | 2.6 | 2.6 | 2.5 | 3.0 | 2.3 | 4.0 | 2.9 | 5.2 | 5.5 | 5.7 | 8.3 | 7.3 | 4.8 | 4.1 | 2.4 | 3.4 | 3.2 |
Dividend Growth(%) | N/A | -93.6 | -43.0 | -36.6 | 143.4 | 34.0 | N/A | N/A | N/A | N/A | N/A | -34.0 | 3.6 | -68.5 | 532.9 | -25.0 | 16.8 | 17.3 | 6.8 | -0.9 | -15.5 | 33.5 | -34.7 | 31.1 | -34.9 | 23.0 | -27.7 | -26.0 | 26.3 | 66.7 | 30.1 | 112.5 | -32.2 | 8.5 | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 12/31/2000
Portfolio Description
This model portfolio uses Strategic Asset Allocation - Equal Weight
. The allocations are diversified by investing in the 6 major asset classes: Commodity, US Equity, REITs, Fixed Income, Emerging Market Equity, Foreign Equity
that are covered in DUPAGE MEDICAL GROUP LTD PROFIT SHARING 401K PLAN. It then selects one or two funds for each of the 6 major asset classes.
1.Risk allocation: the risk profile of this portfolio 40.
The total allocation of the fixed income assets should be at least 40%.
2.Asset weights: risk assets selected are equally weighted by
default.
3.Fund selection: about one or two top performing funds among 16 available funds in the plan are chosen for each asset selected. They are usually equally weighted within
the asset by default.
4.Rebalance frequency: the portfolio is reviewed by the strategy program monthly
and the above steps are repeated. Asset weights are rebalanced back to target allocation if it is necessary.
5.
Simulation: Performance data before this portfolio went public on
03/31/2021
are obtained from historical simulation. They are hypothetical.